mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.04 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.04 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.04 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.05 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.05 |